Xeraya Capital-backed InterVenn Biosciences raises $34m in Series B round

Xeraya Capital-backed InterVenn Biosciences raises $34m in Series B round

19 November, 2020

InterVenn Biosciences Xeraya Capital

Printed by Unregistered user on Sun, 13 Jul 2025 04:50:36 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Malaysia's Xeraya Capital invests in Congenica's $50m Series C funding round

Malaysia’s Xeraya Capital invests in GreenLight Biosciences’ $102m Series D round

Read more from World

The mystery man who bought $100m worth of tokens from Trump’s crypto business

xAI preparing to raise funds from Saudi’s PIF, others at $200b valuation: report